Richard S. C.

About Richard S. C.

Dr. Richard Creager has more than 40 years of experience in the in vitro diagnostic industry. Currently, I am the co-founder and Managing Partner of NaviDx, a consulting firm dedicated to supporting IVD companies. Previously, I was COO of Healgen Scientific LLC, where I helped obtain the first OTC rapid test for the Influenza Virus and SARS-CoV-2 virus. Before that, I was President of Seegene USA, the US-based division of Seegene Inc, a global developer of infectious disease molecular diagnostic products. Previously, I was a consultant to the National Institutes of Health (NIH) RADx initiative to speed innovation in developing and commercializing COVID-19 diagnostic tests. I was also Senior Vice President and Chief Science Officer for Beckman Coulter, a division of Danaher Corporation. During my career, I led the development of more than 170 IVD products for infectious disease, cardiovascular disease, fertility, and thyroid disease. I also led the development and commercialization of several innovative tests for acute myocardial infarction; AMH, for the assessment of ovarian reserve; and the Prostate Health Index (PHI), a test intended to reduce the number of unnecessary prostate biopsies in men. I have a B.S. from Muhlenberg College, an M.S. from Duquesne University, and a Ph.D. from the University of Pittsburgh School of Medicine. I also attended The Wharton School of Business for Advanced Management Program.

Experience

1. Co-founder and Managing Partner

   Navidx Consulting

   Feb 2024 — Present · US

Education

• Muhlenberg College

  BS, Biology

  1970 — 1974

• The Wharton School

  Executive MBA, Advanced Management

  2005 — 2005

• Duquesne University

  Master of Science - MS, Microbiology, General

• University of Pittsburgh School of Medicine

  PhD, Microbiology

  1976 — 1981

Skills

• R&D
• Molecular Oncology
• Medical Diagnostics
• Strategic Planning
• Biotechnology
• Research and Development (R&D)
• U.s. Food and Drug Administration (Fda)
• Microbiology
• Hardware Diagnostics
• Mergers
• In Vitro
• Intellectual Property
• Leadership
• Fda
• Medical Devices
• Licensing
• Commercialization
• Life Sciences
• Validation
• Biochemistry
• Program Management
• Virology
• Genomics
• Molecular Diagnostics
• Cross-Functional Team Leadership
• Oncology
• Diagnostics
• Product Management
• Lifesciences
• Strategy
• Molecular Biology
• Infectious Diseases
• Product Launch
• Immunoassays
• Danaher Business System
• Pcr
• Immunology
• Assay Development
• Product Development
• Technology Transfer